Ruocco V, Satriano R A, Florio M, Pettinato G, Pisani M
Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli Clinica Dermosifilopatica.
G Ital Dermatol Venereol. 1990 Feb;125(1-2):53-8.
A 53-year-old man presented porokeratosis palmaris, plantaris et disseminata with some features (exacerbation of lesions, in the sun light, zosteriform fashion of them on the trunk and extremities) distinctive of other variants of porokeratosis. Lately, four squamous cell carcinomas had arisen on the areas involved by disease. Histologic study of porokeratosis lesions showed epidermal changes typical of the disease ("cornoid lamella"), but also a mild disorder of malpighian stratification. Neoplasms were removed surgically and the patient was given etretinate orally (75 mg/day for a week, 50 mg/day for a month, 25 mg/day for six months, i.e. up to now), which proved to be effective in improving porokeratosis lesions and preventing the occurrence of other squamous cell carcinomas.
一名53岁男性患有掌跖播散性汗孔角化症,其具有一些有别于其他汗孔角化症变体的特征(皮损加重、在日光下、躯干和四肢呈带状疱疹样分布)。最近,在患病区域出现了4例鳞状细胞癌。汗孔角化症皮损的组织学研究显示出该病典型的表皮变化(“鸡眼样板层”),但也有轻度的马尔皮基层紊乱。肿瘤通过手术切除,患者口服依曲替酯(第1周75毫克/天,第2个月50毫克/天,接下来6个月25毫克/天,即直至目前),这被证明对改善汗孔角化症皮损及预防其他鳞状细胞癌的发生有效。